| |
| |
|
| Insider
Information: |
Bishop John E |
| Relationship: |
SVP, Chief Technology ... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
157,253 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,252,637 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
157,253 |
|
|
| Total
Value |
$8,252,637 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
Senior VP, Pharmaceuti... |
2016-05-19 |
157,253 |
2006-02-17 |
0 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
SVP, Chief Technology ... |
2022-10-14 |
0 |
2021-06-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
167 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2016-02-23 |
4 |
AS |
$9.80 |
$1,000 |
D/D |
(102) |
107,086 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2016-04-19 |
4 |
AS |
$9.57 |
$27,208 |
D/D |
(2,843) |
158,037 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2016-05-19 |
4 |
AS |
$10.20 |
$7,997 |
D/D |
(784) |
157,253 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-03-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,750) |
118,193 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-04-16 |
4 |
D |
$17.08 |
$106,152 |
D/D |
(6,215) |
111,978 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2016-04-18 |
4 |
D |
$9.69 |
$60,136 |
D/D |
(6,206) |
160,880 |
0 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
SVP, Chief Technology Officer |
• – – |
2022-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(47,950) |
0 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
VP Pharma Sciences & Manufact |
• – – |
2006-02-17 |
4 |
OE |
$8.10 |
$177,188 |
D/D |
21,875 |
21,875 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
VP Pharma Sciences & Manufact |
• – – |
2006-07-25 |
4 |
OE |
$8.10 |
$12,150 |
D/D |
1,500 |
1,500 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-05-11 |
4 |
OE |
$15.37 |
$528,591 |
D/D |
33,625 |
137,610 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-06-17 |
4 |
OE |
$12.58 |
$9,863 |
D/D |
784 |
111,164 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-06-18 |
4 |
OE |
$12.58 |
$315,078 |
D/D |
24,529 |
119,943 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2015-06-19 |
4 |
OE |
$15.44 |
$328,471 |
D/D |
21,274 |
118,100 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
VP Pharma Sciences & Manufact |
• – – |
2006-02-17 |
4 |
S |
$24.42 |
$539,292 |
D/D |
(21,875) |
0 |
|
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2012-08-10 |
4 |
S |
$13.58 |
$101,646 |
D/D |
(7,485) |
95,963 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2012-08-29 |
4 |
S |
$14.57 |
$34,924 |
D/D |
(2,397) |
92,852 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior VP, Pharmaceutical Scie |
• – – |
2014-05-23 |
4 |
S |
$12.09 |
$798 |
D/D |
(66) |
110,279 |
0 |
- |
|
167 Records found
|
|
Page 7 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
